Please login to the form below

Not currently logged in
Email:
Password:

Communiqué Awards 2009: Finalists

Entries in the Education and Campaign categories have been reviewed and the list of finalists has now been published.

Entries in the Education and Campaign categories have been reviewed and the list of finalists published.

Once again there was considerable discussion and deliberation due the high standard of work submitted, but after much debate the finalists were confirmed and the winners will be presented on Thursday 9th July at the Grosvenor House hotel, in front of an audience of over 1000 guests from pharmaceutical and healthcare communications companies.

The judges praised excellent examples of best practice and were confident in the rigorous and transparent judging process. Entries in the premier categories will be judged next week and announced on PMLiVE on Friday 5th June. This year's charity is Admiral Nurses and PMGroup are delighted that John Suchet has agreed to speak at the awards to help raise much needed funds for this very worthwhile cause.

More information about the Communiqué Awards including details on how to book a table, online nomination forms for Communiquétor of the Year and the Communiqué Lifetime Achievement Award, along with details about sponsorship opportunites can be found in the dedicated Communiqué Awards section of PMLiVE.

29th May 2009

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics